Usa India Britain Eu covid-19 Coronavirus Progressive Usa India Britain Eu

AstraZeneca claims its Evusheld jab protects against severe Covid-19 or death

Reading now: 333
www.livemint.com

AstraZeneca's tests for treatment of people at risk of death from coronavirus has revealed good results in a late-stage trial, its maker AstraZeneca announced Wednesday.

The British pharmaceutical giant, which has already produced a widely used coronavirus vaccine, said the Evusheld jab "provided clinically and statistically significant protection against progression to severe Covid-19 or death".

The phase-three trial was carried out mostly on participants "at high risk of progression to severe Covid-19", AstraZeneca added in a statement.

A total 903 patients worldwide took part in the testing. "Despite the success of vaccines, many individuals such as older adults, individuals with co-morbidities and those who are immunocompromised, remain at risk for poor outcomes from severe Covid-19," said trial lead Hugh Montgomery, professor of intensive care medicine at University College London. "Additional options are needed to prevent disease progression and reduce the burden on healthcare systems, especially with the continued emergence of new variants." Evusheld, for the prevention of Covid-19 in people aged 12 and above or those who already have mild coronavirus, consists of two antibodies.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

IRDA agrees to look into Covid-19 insurance claims - livemint.com - India - city Mumbai
livemint.com
39%
405
IRDA agrees to look into Covid-19 insurance claims
MUMBAI : The Insurance Regulatory and Development Authority (IRDA) on Monday agreed to look into the Covid-19 policy claims that were rejected by insurance companies.  This comes after a public interest litigation was filed by a Manav Seva Dham (petitioner), a social services’ trust against various insurance companies before the Bombay High Court.  According to the petition, it has been alleged that various insurance providers engaged in a number of offences, misusing policyholder funds, rerouting funds through additional businesses, and paying exorbitant overriding commissions to banks and their agents.  “The insurance companies are unjustly denying their Covid-19-related claims, it claimed, even in the midst of the ongoing pandemic Covid-19, in which the country’s residents have not only lost their jobs but also depleted their money", it said.  Additionally, the petitioner submitted that Insurance companies have caused wrongful losses to the policyholders.  Essentially the petitioner asked the court to ass an order to ensure that the insurance claims submitted by the policyholders due to Covid-19 pandemic were not arbitrarily rejected.  The petition stated that due to the widespread pandemic the general insurance companies received a significant lot of claims from the policyholders. More than 80, 000 claims were received by the non-life insurance industry.
DMCA